Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precancerous Conditions 26Neoplasms 8Obesity-Related Malignant Neoplasm 7Myelodysplastic Syndromes 5Leukemia, Myeloid, Acute 5Leukemia 5Uterine Cervical Neoplasms 4Preleukemia 4Neoplasms by Histologic Type 4Hematologic Diseases 4Bone Marrow Diseases 4Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Biphenotypic, Acute 3Keratosis, Actinic 3Immunoproliferative Disorders 3Immune System Diseases 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Advanced Malignant Neoplasm 3Uterine Cervical Dysplasia 2Thrombocythemia, Essential 2Stomach Neoplasms 2Skin Diseases 2Neoplasms by Site 2Myelodysplastic-Myeloproliferative Diseases 2

Interventions

toripalimab 1potassium oxonate 1gimeracil 1apatinib 1Tegafur 1Nivolumab 1Gemcitabine 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Neoplasms of Digestive Organs × Other neoplasm × 1 year × Clear all
NCT05934331 2025-09-12

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

LaNova Medicines Limited

Phase 2 Recruiting
276 enrolled
Other neoplasm

Malignant Neoplasms of Digestive Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡